Annual D&A
$833.00 K
+$89.00 K+11.96%
31 December 2023
Summary:
Inozyme Pharma annual depreciation & amortization is currently $833.00 thousand, with the most recent change of +$89.00 thousand (+11.96%) on 31 December 2023. During the last 3 years, it has risen by +$616.00 thousand (+283.87%). INZY annual D&A is now at all-time high.INZY Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$195.00 K
+$7000.00+3.72%
30 September 2024
Summary:
Inozyme Pharma quarterly depreciation & amortization is currently $195.00 thousand, with the most recent change of +$7000.00 (+3.72%) on 30 September 2024. Over the past year, it has dropped by -$13.00 thousand (-6.25%). INZY quarterly D&A is now -6.70% below its all-time high of $209.00 thousand, reached on 30 June 2023.INZY Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$774.00 K
-$13.00 K-1.65%
30 September 2024
Summary:
Inozyme Pharma TTM depreciation & amortization is currently $774.00 thousand, with the most recent change of -$13.00 thousand (-1.65%) on 30 September 2024. Over the past year, it has dropped by -$48.00 thousand (-5.84%). INZY TTM D&A is now -7.08% below its all-time high of $833.00 thousand, reached on 31 December 2023.INZY TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INZY Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.0% | -6.3% | -5.8% |
| 3 y3 years | +283.9% | +16.8% | +25.9% |
| 5 y5 years | +3103.8% | +875.0% | +1234.5% |
INZY Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +283.9% | -6.7% | +16.8% | -7.1% | +25.9% |
| 5 y | 5 years | at high | +3103.8% | -6.7% | +875.0% | -7.1% | +1234.5% |
| alltime | all time | at high | +3103.8% | -6.7% | +926.3% | -7.1% | +3973.7% |
Inozyme Pharma Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $195.00 K(+3.7%) | $774.00 K(-1.7%) |
| June 2024 | - | $188.00 K(+3.3%) | $787.00 K(-2.6%) |
| Mar 2024 | - | $182.00 K(-12.9%) | $808.00 K(-3.0%) |
| Dec 2023 | $833.00 K(+12.0%) | $209.00 K(+0.5%) | $833.00 K(+1.3%) |
| Sept 2023 | - | $208.00 K(-0.5%) | $822.00 K(+2.4%) |
| June 2023 | - | $209.00 K(+1.0%) | $803.00 K(+3.9%) |
| Mar 2023 | - | $207.00 K(+4.5%) | $773.00 K(+3.9%) |
| Dec 2022 | $744.00 K(+10.4%) | $198.00 K(+4.8%) | $744.00 K(+2.2%) |
| Sept 2022 | - | $189.00 K(+5.6%) | $728.00 K(+3.1%) |
| June 2022 | - | $179.00 K(+0.6%) | $706.00 K(+1.7%) |
| Mar 2022 | - | $178.00 K(-2.2%) | $694.00 K(+3.0%) |
| Dec 2021 | $674.00 K | $182.00 K(+9.0%) | $674.00 K(+9.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $167.00 K(0.0%) | $615.00 K(+25.3%) |
| June 2021 | - | $167.00 K(+5.7%) | $491.00 K(+40.3%) |
| Mar 2021 | - | $158.00 K(+28.5%) | $350.00 K(+61.3%) |
| Dec 2020 | $217.00 K(+161.4%) | $123.00 K(+186.0%) | $217.00 K(+82.4%) |
| Sept 2020 | - | $43.00 K(+65.4%) | $119.00 K(+24.0%) |
| June 2020 | - | $26.00 K(+4.0%) | $96.00 K(+7.9%) |
| Mar 2020 | - | $25.00 K(0.0%) | $89.00 K(+7.2%) |
| Dec 2019 | $83.00 K(+219.2%) | $25.00 K(+25.0%) | $83.00 K(+43.1%) |
| Sept 2019 | - | $20.00 K(+5.3%) | $58.00 K(+52.6%) |
| June 2019 | - | $19.00 K(0.0%) | $38.00 K(+100.0%) |
| Mar 2019 | - | $19.00 K | $19.00 K |
| Dec 2018 | $26.00 K | - | - |
FAQ
- What is Inozyme Pharma annual depreciation & amortization?
- What is the all time high annual D&A for Inozyme Pharma?
- What is Inozyme Pharma annual D&A year-on-year change?
- What is Inozyme Pharma quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Inozyme Pharma?
- What is Inozyme Pharma quarterly D&A year-on-year change?
- What is Inozyme Pharma TTM depreciation & amortization?
- What is the all time high TTM D&A for Inozyme Pharma?
- What is Inozyme Pharma TTM D&A year-on-year change?
What is Inozyme Pharma annual depreciation & amortization?
The current annual D&A of INZY is $833.00 K
What is the all time high annual D&A for Inozyme Pharma?
Inozyme Pharma all-time high annual depreciation & amortization is $833.00 K
What is Inozyme Pharma annual D&A year-on-year change?
Over the past year, INZY annual depreciation & amortization has changed by +$89.00 K (+11.96%)
What is Inozyme Pharma quarterly depreciation & amortization?
The current quarterly D&A of INZY is $195.00 K
What is the all time high quarterly D&A for Inozyme Pharma?
Inozyme Pharma all-time high quarterly depreciation & amortization is $209.00 K
What is Inozyme Pharma quarterly D&A year-on-year change?
Over the past year, INZY quarterly depreciation & amortization has changed by -$13.00 K (-6.25%)
What is Inozyme Pharma TTM depreciation & amortization?
The current TTM D&A of INZY is $774.00 K
What is the all time high TTM D&A for Inozyme Pharma?
Inozyme Pharma all-time high TTM depreciation & amortization is $833.00 K
What is Inozyme Pharma TTM D&A year-on-year change?
Over the past year, INZY TTM depreciation & amortization has changed by -$48.00 K (-5.84%)